About DENDREON PHARMACEUTICALS LLC
Dendreon is a commercial-stage biopharmaceutical company specializing in cellular therapy, known for developing PROVENGE (sipuleucel-T), the first FDA-approved cellular immunotherapy. The company provides end-to-end manufacturing services for cell therapies and has extensive experience in research, development, and commercialization.
Cellular therapy manufacturingResearch and development of immunotherapiesEnd-to-end manufacturing services for cell therapiesStrategic partnerships for advancing cell therapy development
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to DENDREON PHARMACEUTICALS LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.